About Us
Our Science & Programs
Our Technology & Manufacturing
Collaborations
Join Us
中文
About Us
Our Science & Programs
Our Technology & Manufacturing
Collaborations
Join Us
中文
News
2023-05-03
Skyline Therapeutics to Present at the ASGCT 26th Annual Meeting
2022-12-16
Skyline Therapeutics’ Novel AAV Gene Therapy for Ocular Disease Enters Clinical Trial
2022-01-10
China Eye Valley and Skyline Therapeutics sign memorandum of understanding to jointly advance ocular gene therapy practices
2022-01-01
Skyline announces Chief Development Officer as it advances multiple innovative research programs towards clinical stage
2021-12-17
BioMarin and Skyline Therapeutics Announce Strategic Collaboration to Develop Novel Gene Therapies for Cardiovascular Diseases
2021-09-28
Skyline’s GMP manufacturing plant successfully completes large-scale high-quality viral vector production
2020-08-17
Geneception (now Skyline Therapeutics) R&D center launches in Zhangjiang Science City, equipped with cutting-edge gene therapy platforms